<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Consilium Medicum</journal-id><journal-title-group><journal-title xml:lang="en">Consilium Medicum</journal-title><trans-title-group xml:lang="ru"><trans-title>Consilium Medicum</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Consilium Medicum</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-1753</issn><issn publication-format="electronic">2542-2170</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">678412</article-id><article-id pub-id-type="doi">10.26442/20751753.2025.2.203150</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Reversible cerebral vasoconstriction syndrome: A review</article-title><trans-title-group xml:lang="ru"><trans-title>Синдром обратимой церебральной вазоконстрикции</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6061-8118</contrib-id><name-alternatives><name xml:lang="en"><surname>Kulesh</surname><given-names>Aleksey A.</given-names></name><name xml:lang="ru"><surname>Кулеш</surname><given-names>Алексей Александрович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>д-р мед. наук, проф., зав. каф. интегративной медицины ФГБОУ ВО «ПГМУ им. акад. Е.А. Вагнера»; зав. неврологическим отд-нием для больных с острыми нарушениями мозгового кровообращения Регионального сосудистого центра ГАУЗ ПК «ГКБ №4»</p></bio><email>aleksey.kulesh@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2670-4172</contrib-id><name-alternatives><name xml:lang="en"><surname>Demin</surname><given-names>Dmitry A.</given-names></name><name xml:lang="ru"><surname>Демин</surname><given-names>Дмитрий Алексеевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>канд. мед. наук, врач-невролог</p></bio><email>aleksey.kulesh@gmail.com</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8350-7004</contrib-id><name-alternatives><name xml:lang="en"><surname>Starikova</surname><given-names>Natalia L.</given-names></name><name xml:lang="ru"><surname>Старикова</surname><given-names>Наталья Леонидовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>д-р мед. наук, проф. каф. интегративной медицины</p></bio><email>aleksey.kulesh@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5679-4100</contrib-id><name-alternatives><name xml:lang="en"><surname>Mekhryakov</surname><given-names>Sergey A.</given-names></name><name xml:lang="ru"><surname>Мехряков</surname><given-names>Сергей Александрович</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>канд. мед. наук, ассистент каф. интегративной медицины ФГБОУ ВО «ПГМУ им. акад. Е.А. Вагнера»; врач ультразвуковой диагностики ГАУЗ ПК «ГКБ №4»</p></bio><email>aleksey.kulesh@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3785-1154</contrib-id><name-alternatives><name xml:lang="en"><surname>Kayleva</surname><given-names>Nadezhda A.</given-names></name><name xml:lang="ru"><surname>Кайлева</surname><given-names>Надежда Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>канд. мед. наук, ассистент каф. интегративной медицины ФГБОУ ВО «ПГМУ им. акад. Е.А. Вагнера», врач-рентгенолог ГАУЗ ПК «ГКБ №4»</p></bio><email>aleksey.kulesh@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Vagner Perm State Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Пермский государственный медицинский университет им. акад. Е.А. Вагнера» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">City Clinical Hospital №4</institution></aff><aff><institution xml:lang="ru">ГАУЗ ПК «Городская клиническая больница №4»</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Federal Center for Cardiovascular Surgery</institution></aff><aff><institution xml:lang="ru">ФГБУ «Федеральный центр сердечно-сосудистой хирургии» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2025-02-12" publication-format="electronic"><day>12</day><month>02</month><year>2025</year></pub-date><volume>27</volume><issue>2</issue><issue-title xml:lang="en">Neurology and rheumatology</issue-title><issue-title xml:lang="ru">Неврология и ревматология</issue-title><fpage>63</fpage><lpage>69</lpage><history><date date-type="received" iso-8601-date="2025-04-11"><day>11</day><month>04</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-04-11"><day>11</day><month>04</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://consilium.orscience.ru/2075-1753/article/view/678412">https://consilium.orscience.ru/2075-1753/article/view/678412</self-uri><abstract xml:lang="en"><p>Reversible cerebral vasoconstriction syndrome is a relevant but poorly recognized cause of ischemic stroke in young patients. The syndrome should be suspected in patients with recurrent headaches (especially thunderclap headaches) associated with focal neurological deficits, epileptic seizures, or changes in mental status; taking history for any vasoactive triggers is crucial. The radiological spectrum of reversible cerebral vasoconstriction syndrome is broad and includes infarctions, intracerebral and subarachnoid hemorrhages, as well as posterior reversible encephalopathy. These patterns can unfold during the first 2 weeks, which requires serial neuroimaging; early signs include hyperintensity of the arteries on FLAIR. Delayed serial angiography showing reversible multifocal segmental vasoconstriction is required for verification.</p></abstract><trans-abstract xml:lang="ru"><p>Синдром обратимой церебральной вазоконстрикции − важная, но плохо распознаваемая причина ишемического инсульта у молодых пациентов. Синдром следует заподозрить при наличии рецидивирующей (особенно громоподобной) головной боли в сочетании с очаговым неврологическим дефицитом, эпилептическими припадками или изменением психического статуса, а также важно активно собирать анамнез на предмет наличия вазоактивных триггеров. Радиологический спектр синдрома обратимой церебральной вазоконстрикции широк и включает инфаркты, внутримозговые и субарахноидальные кровоизлияния, а также заднюю обратимую энцефалопатию. Развитие данных паттернов может разворачиваться на протяжении первых 2 нед, что требует динамического проведения нейровизуализации, а к ранним признакам относится гиперинтенсивность артерий на FLAIR. Для верификации необходимо отсроченное выполнение ангиографии в динамике с демонстрацией обратимой мультифокальной сегментарной вазоконстрикции.</p></trans-abstract><kwd-group xml:lang="en"><kwd>reversible cerebral vasoconstriction syndrome</kwd><kwd>thunderclap headache</kwd><kwd>stroke at a young age</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>синдром обратимой церебральной вазоконстрикции</kwd><kwd>громоподобная головная боль</kwd><kwd>инсульт в молодом возрасте</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Ducros A. Reversible cerebral vasoconstriction syndrome. Lancet Neurol. 2012;11(10):906-17. DOI:10.1016/S1474-4422(12)70135-7</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Call GK, Fleming MC, Sealfon S, et al. Reversible cerebral segmental vasoconstriction. Stroke. 1988;19(9):1159-70. DOI:10.1161/01.str.19.9.1159</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med. 2007;146(1):34-44. DOI:10.7326/0003-4819-146-1-200701020-00007</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Singhal AB. Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome as Syndromes of Cerebrovascular Dysregulation. Continuum (Minneap Minn). 2021;27(5):1301-1320. DOI:10.1212/CON.0000000000001037</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Song TJ, Lee KH, Li H, et al. Reversible cerebral vasoconstriction syndrome: a comprehensive systematic review. Eur Rev Med Pharmacol Sci. 2021;25(9):3519-29. DOI:10.26355/eurrev_202105_25834</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Ducros A, Wolff V. The Typical Thunderclap Headache of Reversible Cerebral Vasoconstriction Syndrome and its Various Triggers. Headache. 2016;56(4):657-73. DOI:10.1111/head.12797</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Cheng YC, Kuo KH, Lai TH. A common cause of sudden and thunderclap headaches: reversible cerebral vasoconstriction syndrome. J Headache Pain. 2014;15(1):13. DOI:10.1186/1129-2377-15-13</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Ferrante E, Tassorelli C, Rossi P, et al. Focus on the management of thunderclap headache: from nosography to treatment. J Headache Pain. 2011;12:251-258</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Yeh YC, Fuh JL, Chen SP, Wang SJ. Clinical features, imaging findings and outcomes of headache associated with sexual activity. Cephalalgia. 2010;30(11):1329-35. DOI:10.1177/0333102410364675</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Bahra A. Other primary headaches-thunderclap-, cough-, exertional-, and sexual headache. J Neurol. 2020;267(5):1554-66. DOI:10.1007/s00415-020-09728-0</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Erhart DK, Ludolph AC, Althaus K. RCVS: by clinicians for clinicians-a narrative review. J Neurol. 2023;270(2):673-88. DOI:10.1007/s00415-022-11425-z</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>The International Classification of headache disorders, 3rd edition. Cephalalgia. 2018;38(1):1-211. DOI:10.1177/0333102417738202</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Старикова Н.Л. Громоподобная головная боль: диагностика и лечебная тактика. Российский журнал боли. 2016;3-4:3-7 [Starikova NL. Gromopodobnaia golovnaia bol: diagnostika i lechebnaia taktika. Rossiiskii zhurnal boli. 2016;3-4:3-7 (in Russian)].</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Wolff V, Armspach JP, Lauer V, et al. Ischaemic strokes with reversible vasoconstriction and without thunderclap headache: a variant of the reversible cerebral vasoconstriction syndrome? Cerebrovasc Dis. 2015;39(1):31-8. DOI:10.1159/000369776.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Ekker MS, Verhoeven JI, Schellekens MMI, et al. Risk Factors and Causes of Ischemic Stroke in 1322 Young Adults. Stroke. 2023;54(2):439-47.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Kaufmann J, Buecke P, Meinel T, et al. Frequency of ischaemic stroke and intracranial haemorrhage in patients with reversible cerebral vasoconstriction syndrome (RCVS) and posterior reversible encephalopathy syndrome (PRES) – A systematic review. Eur J Neurol. 2024;31(5):e16246. DOI:10.1111/ene.16246.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Chen SP, Wang SJ. Pathophysiology of reversible cerebral vasoconstriction syndrome. J Biomed Sci. 2022;29(1):72. DOI:10.1186/s12929-022-00857-4.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Seok HY, Eun MY, Kim S, et al. Reversible cerebral vasoconstriction syndrome in Guillain-Barre syndrome: a case report and literature review. Neurol Sci. 2024;45(1):101-7. DOI:10.1007/s10072-023-07061-8.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Гудкова В.В., Кимельфельд Е.И., Стаховская Л.В. Малоизвестный синдром задней обратимой энцефалопатии, требующий неотложной помощи. Consilium Medicum. 2018;20(2):84-9 [Gudkova VV, Kimelfeld EI, Stakhovskaya LV. Under-reported posterior reversible encephalopathy syndrome that requires emergency management. Consilium Medicum. 2018;20(2):84-9 (in Russian)]. DOI:10.26442/2075-1753_2018.2.84-89</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Wolff V, Ducros A. Reversible Cerebral Vasoconstriction Syndrome Without Typical Thunderclap Headache. Headache. 2016;56(4):674-87. DOI:10.1111/head.12794</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Cappelen-Smith C, Calic Z, Cordato D. Reversible Cerebral Vasoconstriction Syndrome: Recognition and Treatment. Curr Treat Options Neurol. 2017;19(6):21. DOI:10.1007/s11940-017-0460-7</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Lin PT, Chen SP, Wang SJ. Update on primary headache associated with sexual activity and primary thunderclap headache. Cephalalgia. 2023;43(3):3331024221148657. DOI:10.1177/03331024221148657</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Ducros A, Boukobza M, Porcher R, et al. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007;130(Pt 12):3091-101. DOI:10.1093/brain/awm256</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Mawet J, Debette S, Bousser MG, Ducros A. The Link Between Migraine, Reversible Cerebral Vasoconstriction Syndrome and Cervical Artery Dissection. Headache. 2016;56(4):645-56. DOI:10.1111/head.12798</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Pilato F, Distefano M, Calandrelli R. Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome: Clinical and Radiological Considerations. Front Neurol. 2020;11:34. DOI:10.3389/fneur.2020.00034</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Кулеш А.А., Демин Д.А., Виноградов О.И. Цервикальная диссекция в экстренной неврологии: алгоритмы диагностики и лечения. Российский неврологический журнал. 2022;27(4):86-96 [Kulesh AA, Demin DA, Vinogradov OI. Cervical dissection in emergency neurology: diagnostic and treatment algorithms. Russian neurological journal. 2022;27(4):86-96 (in Russian)].</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Perillo T, Paolella C, Perrotta G, et al. Reversible cerebral vasoconstriction syndrome: review of neuroimaging findings. Radiol Med. 2022;127(9):981-90. DOI:10.1007/s11547-022-01532-2</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Burton TM, Bushnell CD. Reversible Cerebral Vasoconstriction Syndrome. Stroke. 2019;50(8):2253-8. DOI:10.1161/STROKEAHA.119.024416</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Sivagurunathan GM, Khan A, Fotopoulos D. Radiological Findings in Reversible Cerebral Vasoconstriction Syndrome: A Systematic Review of Literature. Cureus. 2024;16(5):e59595. DOI:10.7759/cureus.59595</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Chen SP, Fuh JL, Lirng JF, Wang SJ. Hyperintense vessels on flair imaging in reversible cerebral vasoconstriction syndrome. Cephalalgia. 2012;32(4):271-8. DOI:10.1177/0333102412437387</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Murase S, Gon Y, Watanabe A, et al. Isolated cortical vasogenic edema and hyperintense vessel signs may be early features of reversible cerebral vasoconstriction syndrome: Case reports. Cephalalgia. 2018;38(6):1207-10. DOI:10.1177/0333102417731779</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Kameda T, Namekawa M, Shimazaki H, et al. Unique combination of hyperintense vessel sign on initial FLAIR and delayed vasoconstriction on MRA in reversible cerebral vasoconstriction syndrome: a case report. Cephalalgia. 2014;34(13):1093-6. DOI:10.1177/0333102414529197</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Itsekson-Hayosh Z, Tsarfaty G, Greenberg G, et al. Early Fluid Attenuation Inversion Recovery Sulcal Contrast Enhancement Correlates with Severity of Reversible Cerebral Vasoconstriction Syndrome. J Stroke. 2021;23(1):146. DOI:10.5853/jos.2020.01004.e1</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Singhal AB, Hajj-Ali RA, Topcuoglu MA, et al. Reversible cerebral vasoconstriction syndromes: analysis of 139 cases. Arch Neurol. 2011;68(8):1005-12. DOI:10.1001/archneurol.2011.68</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Ducros A, Fiedler U, Porcher R, et al. Hemorrhagic manifestations of reversible cerebral vasoconstriction syndrome: frequency, features, and risk factors. Stroke. 2010;41(11):2505-11. DOI:10.1161/STROKEAHA.109.572313</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Noguchi S, Miyaoka R, Miyachi H. Clinical Images: Symmetrical Gyriform Restricted Diffusion in Severe Reversible Cerebral Vasoconstriction Syndrome. World Neurosurg. 2023;177:86-7. DOI:10.1016/j.wneu.2023.06.042</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Strunk D, Veltkamp R, Meuth SG, et al. Intra-arterial application of nimodipine in reversible cerebral vasoconstriction syndrome: a neuroradiological method to help differentiate from primary central nervous system vasculitis. Neurol Res Pract. 2022;4(1):8. DOI:10.1186/s42466-022-00173-0</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Sequeiros JM, Roa JA, Sabotin RP, et al. Quantifying Intra-Arterial Verapamil Response as a Diagnostic Tool for Reversible Cerebral Vasoconstriction Syndrome. AJNR Am J Neuroradiol. 2020;41(10):1869-75.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Merli N, Padroni M, Azzini C, et al. Reversible cerebral vasoconstriction syndrome: strategies to early diagnosis and the role of transcranial color-coded doppler ultrasonography (TCCD). Neurol Sci. 2023;44(7):2541-5. DOI:10.1007/s10072-023-06755-3</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Hathidara M, Patel NH, Flores A, et al. Transcranial Doppler findings in reversible cerebral vasoconstriction syndrome. J Neuroimaging. 2022;32(2):345-51. DOI:10.1111/jon.12946</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Robba C, Taccone FS. How I use Transcranial Doppler. Crit Care. 2019 Dec 23;23(1):420. DOI:10.1186/s13054-019-2700-6</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Sharma VK, Tsivgoulis G, Lao AY, et al. Noninvasive detection of diffuse intracranial disease. Stroke. 2007;38(12):3175-81.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Кулеш А.А. Церебральный венозный тромбоз и его геморрагические осложнения. Неврология, нейропсихиатрия, психосоматика. 2021;13(2):10-8 [Kulesh AA. Cerebral venous thrombosis and its hemorrhagic complications. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(2):10-8 (in Russian)].</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Кулеш А.А., Демин Д.А., Гусева А.Л., и др. Вестибулярное головокружение в неотложной неврологии. Российский неврологический журнал. 2021;26(4):50-9 [Kulesh AA, Dyomin DA, Guseva AL, et al. Vestibular vertigo in emergency neurology. Russian neurological journal. 2021;26(4):50-9 (in Russian)].</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Edlow JA, Newman-Toker DE, Savitz SI. Diagnosis and initial management of cerebellar infarction. Lancet Neurol. 2008;7(10):951-64. DOI:10.1016/S1474-4422(08)70216-3</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Barkhoudarian G, Kelly DF. Pituitary Apoplexy. Neurosurg Clin N Am. 2019;30(4):457-63. DOI:10.1016/j.nec.2019.06.001</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Cho S, Lee MJ, Chung CS. Effect of Nimodipine Treatment on the Clinical Course of Reversible Cerebral Vasoconstriction Syndrome. Front Neurol. 2019;10:644. DOI:10.3389/fneur.2019.00644.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Avola G, Pezzini A. Treatment-Related Reversible Cerebral Vasoconstriction Syndrome. J Clin Med. 2024;13(19):5930. DOI:10.3390/jcm13195930.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Elstner M, Linn J, Müller-Schunk S, Straube A. Reversible cerebral vasoconstriction syndrome: a complicated clinical course treated with intra-arterial application of nimodipine. Cephalalgia. 2009;29(6):677-82. DOI:10.1111/j.1468-2982.2008.01768.x</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Ospel JM, Wright CH, Jung R, et al. Intra-Arterial Verapamil Treatment in Oral Therapy-Refractory Reversible Cerebral Vasoconstriction Syndrome. AJNR Am J Neuroradiol. 2020;41(2):293-9. DOI:10.3174/ajnr.A6378.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Singhal AB, Topcuoglu MA. Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome. Neurology. 2017;88(3):228-36. DOI:10.1212/WNL.0000000000003510</mixed-citation></ref></ref-list></back></article>
